Vitamin D Supplementation in Adult Crohn's Disease (VITD-CD)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01369667
: June 9, 2011
Last Update Posted
: August 18, 2015
University of Dublin, Trinity College
Queen Mary University of London
Information provided by (Responsible Party):
Tara Raftery, University of Dublin, Trinity College
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 75 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
All patients must fulfill the clinical criteria for diagnosis of Crohn's disease.
Subjects must have inactive CD as defined by CDAI < 150
CRP </=10 mg/L.
Pregnant and lactating women.
Known hypersensitivity to vitamin D.
Current supplemental intake of vitamin D3 >800 IU/D.
Diagnosis of any of the following: active tuberculosis, sarcoidosis, hyperparathyroidism, pseudohyperparathyroidism, renal failure or malignancy, active TB, sarcoidosis, lymphoma.